Bionomics
a differentiated approach the nicotinic acetylcholine receptor | Bionomics
Company
Deck Type
IPO
Sector
Industry
Deck date
December 2021
Slide
7 of 38
Related slides by other companies
Alkermes
Investor Day
March 2021
design goals differentiated receptor agonist to address unmet patient needs robust efficacy convenient dosing favorable tolerability increased wakefulness once daily oral medication duration improved cataplexy control dose to allow for hours wakefulness with no later insomnia reduced risk of heart rate and blood pressure effects seen with stimulants | Alkermes
Alkermes
Investor Conference
January 2022
objective novel drug development with differentiated and disciplined approach | Alkermes
First Republic Bank
Investor Day
November 2022
a differentiated approach first republic | First Republic Bank
Other recent decks by Bionomics
See all presentations (5 decks)
Results
March 2023
Investor Presentation
October 2022
Investor Presentation
June 2022
Investor Presentation
April 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io